SIGLEC1 and melanoma: In pre-metastatic LN, melanoma-derived EVs fuse with subcapsular sinus CD169+ macrophages to avoid immune recognition, while the destruction of subcapsular sinus CD169+ macrophages allows EVs to enter the LN cortex to interact with B cells and activate pro-inflammatory cells tumor B cell immunity (98).